Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation (2013)
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Ted Gooley, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Andrew Shields, University of Washington
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Rainer F. Storb, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 2, 2013
DOI
10.1016/j.bbmt.2012.11.054
Citation Information
Raya Mawad, Ted Gooley, Joseph G. Rajendran, Darrell R. Fisher, et al.. "Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation" Biology of Blood and Marrow Transplantation Vol. 19 Iss. 2 (2013)
Available at: http://works.bepress.com/john-pagel/134/